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Infection of cells by microorganisms activates the inflammatory response. The initial sensing of
infection is mediated by innate pattern recognition receptors (PRRs), which include Toll-like recep-
tors,RIG-I-like receptors,NOD-like receptors, andC-type lectin receptors.The intracellular signaling
cascades triggeredby thesePRRs lead to transcriptional expressionof inflammatorymediators that
coordinate the elimination of pathogens and infected cells. However, aberrant activation of this
system leads to immunodeficiency, septic shock, or induction of autoimmunity. In this Review, we
discuss the role of PRRs, their signaling pathways, and how they control inflammatory responses.Introduction
Inflammation is a protective response by the body to ensure
removal of detrimental stimuli, as well as a healing process for
repairing damaged tissue (Medzhitov, 2008). Inflammation is
caused by various factors such as microbial infection, tissue
injury, and cardiac infarction. Classically, inflammation is charac-
terized by five symptoms: redness, swelling, heat, pain, and loss
of tissue function. These macroscopic symptoms reflect
increased permeability of the vascular endothelium allowing
leakage of serum components and extravasation of immune
cells. The inflammatory response is then rapidly terminated
and damaged tissues are repaired. However, overproduction
of cytokines (a cytokine storm) by immune cells to overwhelm
pathogens can be fatal. A cytokine storm can also be caused
by noninfectious diseases such as graft-versus-host disease
(GVHD). Inflammatory responses are also critical for the patho-
genesis of autoimmune diseases.
The innate immune system is the major contributor to acute
inflammation induced by microbial infection or tissue damage
(Akira et al., 2006; Beutler et al., 2006). Furthermore, innate
immunity is also important for the activation of acquired immu-
nity. Although innate immune cells including macrophages and
dendritic cells (DCs) play important roles, nonprofessional cells
such as epithelial cells, endothelial cells, and fibroblasts also
contribute to innate immunity. Germline-encoded pattern recog-
nition receptors (PRRs) are responsible for sensing the presence
of microorganisms. They do this by recognizing structures
conserved among microbial species, which are called path-
ogen-associated molecular patterns (PAMPs). Recent evidence
indicates that PRRs are also responsible for recognizing endog-
enousmolecules released from damaged cells, termed damage-
associated molecular patterns (DAMPs). Currently, four different
classes of PRR families have been identified. These families
include transmembrane proteins such as the Toll-like receptors
(TLRs) and C-type lectin receptors (CLRs), as well as cyto-
plasmic proteins such as the Retinoic acid-inducible gene
(RIG)-I-like receptors (RLRs) and NOD-like receptors (NLRs).These PRRs are expressed not only in macrophages and DCs
but also in various nonprofessional immune cells. With the
exception of some NLRs, the sensing of PAMPs or DAMPs by
PRRs upregulates the transcription of genes involved in inflam-
matory responses. These genes encode proinflammatory cyto-
kines, type I interferons (IFNs), chemokines and antimicrobial
proteins, proteins involved in the modulation of PRR signaling,
and many uncharacterized proteins. The expression patterns
of the inducible genes differ among activated PRRs.
The inflammatory response is orchestrated by proinflamma-
tory cytokines such as tumor necrosis factor (TNF), interleukin
(IL)-1, and IL-6. These cytokines are pleiotropic proteins that
regulate the cell death of inflammatory tissues, modify vascular
endothelial permeability, recruit blood cells to inflamed tissues,
and induce the production of acute-phase proteins. Although
TNF and IL-6 are mainly regulated at the transcriptional and
translational levels, the production of IL-1b is regulated by
a two-step mechanism. The first step is the expression of an
IL-1b zymogen, pro-IL-1b, which is regulated by the synthesis
of its mRNA in a TLR signal-dependent manner. However, IL-1b
maturation requires cleavage of pro-IL-1b by a protease, cas-
pase-1, which is activated independently of TLR signaling. The
complex that activates caspase-1, called the inflammasome, is
composed of NLRs, ASC, and caspase-1 (see Review by
K. Schroder and J. Tschopp on page 821 of this issue). Type I
IFNs, including multiple forms of IFN-a and single forms of
IFN-b, IFN-u, etc., are also involved in the modulation of inflam-
mation (Honda et al., 2006). Type I IFNs play central roles in anti-
viral responses by inducing apoptotic cell death in virally infected
cells, rendering cells resistant to virus infection, activating
acquired immunity, and stimulating hematopoietic stem cell
turnover and proliferation. Secreted type I IFNs alert the
surrounding cells via type I IFN receptors by triggering a signaling
cascade that leads to the phosphorylation and nuclear translo-
cation of IFN-stimulated gene factor 3 (ISGF3), a complex
composed of Signal Transducers and Activators of Transcription
1 (STAT1), STAT2, and IFN-regulatory factor (IRF) 9. ISGF3Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc. 805
Table 1. PRRs and Their Ligands
PRRs Localization Ligand Origin of the Ligand
TLR
TLR1 Plasma membrane Triacyl lipoprotein Bacteria
TLR2 Plasma membrane Lipoprotein Bacteria, viruses, parasites, self
TLR3 Endolysosome dsRNA Virus
TLR4 Plasma membrane LPS Bacteria, viruses, self
TLR5 Plasma membrane Flagellin Bacteria
TLR6 Plasma membrane Diacyl lipoprotein Bacteria, viruses
TLR7 (human TLR8) Endolysosome ssRNA Virus, bacteria, self
TLR9 Endolysosome CpG-DNA Virus, bacteria, protozoa, self
TLR10 Endolysosome Unknown Unknown
TLR11 Plasma membrane Profilin-like molecule Protozoa
RLR
RIG-I Cytoplasm Short dsRNA, 50triphosphate dsRNA RNA viruses, DNA virus
MDA5 Cytoplasm Long dsRNA RNA viruses (Picornaviridae)
LGP2 Cytoplasm Unknown RNA viruses
NLR
NOD1 Cytoplasm iE-DAP Bacteria
NOD2 Cytoplasm MDP Bacteria
CLR
Dectin-1 Plasma membrane b-Glucan Fungi
Dectin-2 Plasma membrane b-Glucan Fungi
MINCLE Plasma membrane SAP130 Self, fungiinduces expression of IFN-inducible antiviral genes such as
protein kinase R (PKR) and 2050-oligoadenylate synthase (OAS)
among others. PKR suppresses the proliferation of virus-in-
fected cells and 2050-OAS activates RNase L, which cleaves viral
nucleotides in order to inhibit virus replication.
In this Review, we discuss how distinct PRRs (with particular
emphasis on TLRs and RLRs) sense the presence of pathogens
and cellular insults and the mechanisms by which these PRR
signals elicit inflammation.
TLRs and Their Ligands
The TLR family is one of the best-characterized PRR families and
is responsible for sensing invading pathogens outside of the cell
and in intracellular endosomes and lysosomes (Akira et al.,
2006). TLRs are characterized by N-terminal leucine-rich repeats
(LRRs) and a transmembrane region followed by a cytoplasmic
Toll/IL-1R homology (TIR) domain. Ten TLRs have been identi-
fied in humans and 12 in mice. Different TLRs recognize the
different molecular patterns of microorganisms and self-compo-
nents (Table 1).
TLR2 senses various components from bacteria, myco-
plasma, fungi, and viruses. These components include the lipo-
proteins of bacteria and mycoplasma. TLR2 recognizes its
ligands by forming a heterodimer with either TLR1 or TLR6
(Figure 1). The resulting TLR1/TLR2 and TLR6/TLR2 complexes
recognize distinct ligands (triacyl and diacyl lipoproteins,
respectively). The crystal structures of the extracellular domains
of TLR2, TLR1, and TLR6 revealed that they form M-shaped806 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.structures and that their cognate ligands interact with internal
pockets formed by the TLR1/TLR2 or TLR6/TLR2 heterodimers
(Jin et al., 2007). Stimulation with TLR2 ligands, such as triacyl
and diacyl lipoproteins, induces the production of various proin-
flammatory cytokines (but not type I IFNs) in macrophages and
DCs. However, another report showed that TLR2 in inflammatory
monocytes induced type I IFNs in response to viral infection,
suggesting that the cellular responses to TLR2 ligands differ de-
pending on the cell types involved (Barbalat et al., 2009). TLR10
is related to TLR1 and TLR6 based on sequence similarity.
TLR10 seems to be functional in humans, although mouse
TLR10 is disrupted by insertion of an endogenous retrovirus.
The ligand for TLR10 has not been identified.
TLR4 recognizes lipopolysaccharide (LPS) together with
myeloid differentiation factor 2 (MD2) on the cell surface. LPS
is a component derived from the outer membrane of Gram-
negative bacteria and is known to be a cause of septic shock.
The crystal structure of a complex comprising TLR4, MD2, and
LPS revealed that two complexes of TLR4-MD2-LPS interact
symmetrically to form a TLR4 homodimer (Park et al., 2009).
TLR4 is also involved in the recognition of viruses by binding to
viral envelope proteins. In addition, TLR4 modulates the patho-
genesis of H5N1 avian influenza virus infection by recognizing
a DAMP rather than the virus itself (Imai et al., 2008). Acute
lung injury caused by avian influenza virus infection produces
endogenous oxidized phospholipids, which stimulate TLR4.
Mice lacking TLR4 were found to be resistant to avian flu-
induced lethality.
Figure 1. TLR2, TLR3, and TLR4 Signaling Pathways
Lipoproteins and LPS are recognized on the cell surface by a heterodimer of
TLR1/6 and TLR2, and by 2 sets of TLR4/MD2 complexes, respectively.
Ligand stimulation recruits MyD88 and TIRAP to the TLR, and a complex of
IRAKs and TRAF6 is subsequently formed. TRAF6 acts as an E3 ubiquitin
ligase and catalyzes formation of a K63-linked polyubiquitin chain on TRAF6
itself and generation of an unconjugated polyubiquitin chain with an E2 ubiq-
uitin ligase complex of Ubc13 and Uev1A. Ubiquitination activates a complex
of TAK1, TAB1, and TAB2/3 resulting in the phosphorylation of NEMO and the
activation of an IKK complex. Phosphorylated IkB is degraded, and the freed
NF-kB translocates to the nucleus where it drives expression of cytokine
genes. Simultaneously, TAK1 activates MAP kinase cascades leading to the
activation of AP-1, which is also critical for the induction of cytokine genes.
LPS induces translocation of TLR4 to the endosome together with TRAM.
TLR3 is present in the endosome and recognizes dsRNA. TLR3 and TLR4 acti-
vate TRIF-dependent signaling, which activates NF-kB and IRF3 resulting in
the induction of proinflammatory cytokine genes and type I IFNs. TRAF6 and
RIP1 activate NF-kB, whereas TRAF3 is responsible for phosphorylation of
IRF3 by TBK1/IKK-i. NAP1 and SINTBAD are required for the activation of
TBK1/IKK-i. Phosphorylated IRF3 translocates into the nucleus to induce
expression of type I IFN genes.TLR5 is highly expressed byDCs of the lamina propria (LPDCs)
in the small intestine, where it recognizes flagellin from flagel-
lated bacteria. In response to flagellin, LPDCs induce B cells to
differentiate into IgA-producing plasma cells and trigger thedifferentiation of naive T cells into antigen-specific Th17 and
Th1 cells (Uematsu et al., 2008). TLR11, which is present in
mice but not in humans, shows close homology to TLR5.
TLR11 recognizes uropathogenic bacteria and a profilin-like
molecule derived from the intracellular protozoan Toxoplasma
gondii (Yarovinsky et al., 2005).
A set of TLRs, comprising TLR3, TLR7, TLR8, and TLR9,
recognize nucleic acids derived from viruses and bacteria, as
well as endogenous nucleic acids in pathogenic contexts (Akira
et al., 2006). Activation of these TLRs leads to the production of
type I IFNs in addition to proinflammatory cytokines. TLR3
detects viral double-stranded (ds) RNA in the endolysosome.
TLR3 is involved in the recognition of polyinosinic polycytidylic
acid (poly I:C), a synthetic dsRNA analog. Although inoculation
of mice with poly I:C induces the production of cytokines as
well as type I IFNs in mice, TLR3 is essential for the production
of cytokines such as IL-12p40, but not type I IFNs in sera (Kato
et al., 2006). The crystal structure of TLR3 bound to dsRNA
revealed that dsRNA binds to the N-terminal and C-terminal
portions of TLR3 LRRs, and this ligand binding dimerizes two
TLR3 molecules (Choe et al., 2005; Liu et al., 2008). Mouse
TLR7 and human TLR7/8 recognize single-stranded (ss) RNAs
from RNA viruses, as well as small purine analog compounds
(imidazoquinolines). TLR7 also detects RNAs from bacteria
such as Group B Streptococcus in endolysosomes in conven-
tional DCs (cDCs) (Mancuso et al., 2009). TLR9 senses unmethy-
lated DNA with CpG motifs derived from bacteria and viruses.
Although the CpG motif was thought to be essential for TLR9
stimulation, the DNA sugar backbone of 20 deoxyribose also
mediates TLR9 recognition (Haas et al., 2008). In addition to
DNA, TLR9 also recognizes hemozoin, a crystalline metabolite
of hemoglobin produced by the malaria parasite (Coban et al.,
2005). TLR9 directly binds to hemozoin, and a crude extract of
the malaria parasite elicits parasite-antigen-specific immune
responses via TLR9 (Coban et al., 2010). However, another
report shows that TLR9 recognizes malaria parasite DNA con-
tained in purified hemozoin, and that hemozoin only transports
malaria parasite DNA to the endosome, where TLR9 is present
(Parroche et al., 2007). Further studies will clarify the role of
TLR9 in the recognition of malaria parasite components. TLR7
and TLR9, but not TLR3, are highly expressed in plasmacytoid
DCs (pDCs), a cell type that produces large amounts of type I
IFNs in response to virus infection.
Accumulating evidence underscores the importance of the
localization of TLRs in the cell for their recognition by ligand
(Barton and Kagan, 2009). Given that self-nucleotides are potent
TLR ligands and may facilitate autoimmunity, TLRs that recog-
nize self-nucleotides are compartmentalized to avoid unwanted
activation. Although TLR1, TLR2, TLR4, TLR5, and TLR6 are
present on the plasma membrane, TLR3, TLR7, and TLR9 are
mainly present on the endoplasmic reticulum (ER) membrane.
It has been proposed that self-nucleic acids are degraded by
extracellular or endosomal DNases prior to recognition by
TLRs. Nucleic acid-sensing TLRs are recruited from the ER to
endolysosomes following stimulation by their ligands (Figure 2).
The mechanism by which nucleotide-recognizing TLRs are re-
cruited from the ER to the endolysosome compartment remains
to be clarified. However, a forward genetics screen in miceCell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc. 807
Figure 2. Nucleic Acid Sensing by TLR7 and TLR9
TLR7 and TLR9 recognize viral ssRNA andCpGDNA, respectively. Stimulation
with ligands or infection by viruses induces trafficking of TLR7 and TLR9 from
the ER to the endolysosome via UNC93B1. TLR9 undergoes cleavage by
proteases present in the endolysosome. A complex of MyD88, IRAK-4,
TRAF6, TRAF3, IRAK-1, IKK-a, and IRF7 is recruited to the TLR. Phosphory-
lated IRF7 translocates into the nucleus and upregulates the expression of
type I IFN genes. Viruses that have entered the cytoplasm are engulfed by
autophagosomes and deliver viral nucleic acids to the endolysosome. An
HMGB1-DNA complex released from damaged cells is captured by RAGE.
Autoantibodies recognizing self-DNA or -RNA bind to FcgRIIa. LL37, an anti-
microbial peptide, associates with endogenous DNA. These proteins are
responsible for the delivery of endogenous nucleic acids to endolyosomes
where they are recognized by TLR7 or TLR9.revealed that UNC93B1 (an ER protein with 12 membrane-span-
ning domains) is responsible for TLR3, TLR7, and TLR9 signaling
by governing the translocation of these TLRs from the ER to the
endolysosome (Kim et al., 2008; Tabeta et al., 2006). When TLR9
is recruited from the ER to the endolysosome, it undergoes pro-
cessing by proteases, such as cathepsins, in the endolysosome
(Ewald et al., 2008; Park et al., 2008). The processed form of
TLR9 is responsible for CpG-DNA recognition. It has been shown
that cathepsins B, K, and L and asparagine endopeptidase are
required for TLR9 responses (Asagiri et al., 2008; Matsumoto
et al., 2008; Sepulveda et al., 2009). Currently, it remains unclear808 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.whether TLR7 is also cleaved in the endolysosome, although en-
dosomal acidification is required for the sensing of TLR7 ligands.
TLR7 and TLR9 are essential for virus-induced type I IFN
production by pDCs (Kato et al., 2005). Viral nucleotides can
interact with TLR7 and TLR9 in pDCs after they have been endo-
cytosed. Alternatively, once the viruses invade pDCs and virions
are present in the cytoplasm, they can be delivered to the endo-
lysosome where TLR7 and TLR9 are recruited for viral sensing.
pDCs take advantage of a cellular process called autophagy in
which self-proteins and damaged organelles are degraded in
double-membraned vesicles called autophagosomes (Lee
et al., 2007). In the absence of ATG5, a protein essential for au-
tophagosome formation, pDCs fail to produce type I IFNs in
response to virus infection, suggesting that the cytoplasmic
virions are engulfed by autophagosomes and then fusewith lyso-
somes. However, ATG5 is also required for responses to CpG-
DNA. Therefore, autophagy may control either the endosomal
maturation required for CpG-DNA sensing or the TLR9 signaling
pathways in pDCs, or both.
TLR-mediated microbial recognition is very important for host
defense against pathogens. On the other hand, excess re-
sponses to TLR ligands induce lethal septic shock syndrome.
These observations indicate that appropriate activation of
TLRs is vital for eradicating invading pathogens without causing
harmful damage to the host.
TLR Signaling Pathways
Recognition of PAMPs by TLRs leads to transcriptional upregu-
lation of distinct genes, depending on the TLRs and cell types
involved (Figure 1). The difference in the signaling cascades acti-
vated by the individual TLRs can be partly explained by the TIR
domain-containing adaptor molecules recruited to TLRs
(Akira et al., 2006). There are five TIR domain-containing adap-
tors including MyD88, TIR domain-containing adaptor inducing
IFN-b (TRIF; also known as TICAM-1), TIRAP/Mal, TRIF-related
adaptor molecule (TRAM), and Sterile-alpha and Armadillo
motif-containing protein (SARM). TLR signaling is roughly
divided into two distinct pathways depending on the usage of
the distinct adaptor molecules, MyD88 and TRIF.
The MyD88-Dependent Signaling Pathway
MyD88 is composed of a death domain (DD) in addition to a TIR
domain. MyD88 is essential for the downstream signaling of
various TLRs, with the exception of TLR3. Children with
MyD88 deficiency suffer from recurrent pyogenic bacterial infec-
tions. TLR2 and TLR4 signaling requires TIRAP/Mal for bridging
between TLR and MyD88. MyD88 interacts with IL-1R-associ-
ated kinase (IRAK)-4, a serine/threonine kinase with an N-ter-
minal death domain. IRAK-4 activates other IRAK family
members, IRAK-1 and IRAK-2 (Kawagoe et al., 2008). The IRAKs
then dissociate from MyD88 and interact with TNFR-associated
factor 6 (TRAF6), which acts as an E3 ubiquitin protein ligase.
Together with an E2 ubiquitin-conjugating enzyme complex
comprising Ubc13 and Uev1A, TRAF6 catalyzes the formation
of a lysine 63 (K63)-linked polyubiquitin chain on TRAF6 itself
as well as the generation of an unconjugated free polyubiquitin
chain (Xia et al., 2009). A complex of TGF-b-activated kinase 1
(TAK1), TAK1-binding protein 1 (TAB1), TAB2, and TAB3 is acti-
vated by the unconjugated free K63 polyubiquitin chain and
phosphorylates IkB kinase (IKK)-b and MAP kinase kinase 6.
Subsequently, the IKK complex, composed of IKK-a, IKK-b,
and NF-kB essential modulator (NEMO), phosphorylates IkBa,
an NF-kB inhibitory protein. Phosphorylated IkB undergoes
degradation by the ubiquitin-proteasome system, thereby
freeing NF-kB to translocate into the nucleus and activate
expression of proinflammatory cytokine genes. Activation of the
MAP kinase cascade is responsible for the formation of another
transcription factor complex, AP-1, that targets cytokine genes.
TLR7 and TLR9 signaling induces the production of type I IFNs
in addition to other NF-kB-dependent cytokines in a MyD88-
dependent manner. In pDCs, MyD88 forms a complex with
IRAK-1, TRAF6, TRAF3, IKK-a, and IRF7, and phosphorylated
IRF7 translocates to the nucleus to activate the expression
of genes encoding type I IFNs (Figure 2). In cDCs, IRF1, but
not IRF7, is activated downstream of TLR7 and TLR9, resulting
in the activation of IFN-b gene expression (Negishi et al., 2006;
Schmitz et al., 2007).
The TRIF-Dependent Signaling Pathway
In response to stimulation with dsRNA, TLR3 recruits another
adaptor protein, TRIF. TLR4 triggers both MyD88-dependent
and TRIF-dependent signaling. TLR4, but not TLR3, requires
another adaptor, TRAM, for activating TRIF. A splice variant of
TRAM called the TRAM adaptor with GOLD domain (TAG) acts
as the negative regulator of TRIF-dependent signaling
(Palsson-McDermott et al., 2009). TRIF associates with TRAF3
and TRAF6 through TRAF-binding motifs present in its N-ter-
minal portion. TRIF also contains a C-terminal receptor-interact-
ing protein (RIP) homotypic interaction motif (RHIM) and
interacts with RIP1 and RIP3 via this motif. In humans, SARM
functions as an inhibitor of TRIF-dependent signaling (Carty
et al., 2006). The TNFR-associated death domain protein
(TRADD), an essential adaptor for TNFR signaling, is involved
in the TRIF-dependent signaling pathway (Ermolaeva et al.,
2008; Pobezinskaya et al., 2008). TRADD forms a complex
with FAS-associated death domain-containing protein (FADD)
and RIP1, and TRADD mediates ubiquitination of RIP1, an event
required for NF-kB activation. FADD activates caspase-8 or
caspase-10 in response to poly I:C, and the cleaved form of
caspases activates NF-kB (Takahashi et al., 2006).
TRAF3 is important for activating two IKK-related kinases,
TANK-binding kinase 1 (TBK1) and IKK-i (also known as IKK-3)
(Hacker et al., 2006; Oganesyan et al., 2006). TRAF3 undergoes
K63-linked auto-ubiquitination in response to TLR3 and acts as
an E3 ubiquitin ligase. TRAF3 activation is negatively regulated
by a deubiquitination enzyme DUBA (Kayagaki et al., 2007),
and MyD88-dependent signaling triggers K48-linked ubiquitina-
tion of TRAF3. Proteasome-mediated degradation of TRAF3 is
important for the activation of MAP kinases and the production
of proinflammatory cytokines (Tseng et al., 2009). A recent study
identified an E2 ubiquitin ligase, Ubc5, as amolecule required for
IRF3 activation by catalyzing K63-type polyubiquitin chain
formation (Zeng et al., 2009). TBK1 and IKK-i phosphorylate
IRF3 and IRF7; IRF3 and IRF7 dimers translocate to the nucleus,
resulting in induction of type I IFNs and expression of IFN-induc-
ible genes. IKK-i also phosphorylates STAT1 to facilitate the
induction of a set of IFN-inducible genes including Adar1, Ifit3,
and Irf7 (Tenoever et al., 2007).The activation of TBK1 and IKK-i is modulated by various
proteins. TBK1 and IKK-i interact with TRAF family member-
associated NF-kB activator (TANK) (also known as I-TRAF),
NAK-associated protein 1 (NAP1), and the TBK1 adaptor
(SINTBAD), which is similar to NAP1 (Guo and Cheng, 2007;
Ryzhakov and Randow, 2007; Sasai et al., 2006). These mole-
cules contain a TBK1-binding motif and show similarities in their
coiled-coil domains. However, TANK/ cells do not show
impaired type I IFN production in response to dsRNA stimulation
(Kawagoe et al., 2009). Although knockdown of either NAP1 or
SINTBAD impairs TRIF signaling, the relationship between these
molecules in TRIF signaling is not yet fully understood.
RLRs and Virus Recognition
The RIG-I-like receptor (RLR) family is composed of RIG-I, mela-
noma differentiation-associated gene 5 (MDA5), and LGP2
(Takeuchi and Akira, 2009; Yoneyama and Fujita, 2008). RLRs
are composed of two N-terminal caspase recruitment domains
(CARDs), a central DEAD box helicase/ATPase domain, and
a C-terminal regulatory domain. They are localized in the cyto-
plasm and recognize the genomic RNA of dsRNA viruses and
dsRNA generated as the replication intermediate of ssRNA
viruses. The expression of RLRs is greatly enhanced in response
to type I IFN stimulation or virus infection.
Mouse fibroblasts and cDCs lacking RIG-I are defective in the
production of type I IFNs and inflammatory cytokines in
response to various RNA viruses (Kato et al., 2006). These
include the Paramyxoviridae such as Newcastle disease virus
(NDV) and Sendai virus (SeV), vesicular stomatitis virus (VSV),
influenza virus, and Japanese encephalitis virus (JEV). In
contrast, cells lacking MDA5 respond normally to these viruses.
Meanwhile, the IFN responses to several Picornaviridae,
including encephalomyocarditis virus (EMCV), Mengo virus,
and Theiler’s virus, are abrogated in MDA5/ cells, but not in
cells lacking RIG-I. In addition to JEV, another flavivirus, hepatitis
C virus (HCV), is also recognized by RIG-I, whereas both RIG-I
and MDA5 redundantly recognize Dengue virus and West Nile
virus (Loo et al., 2008; Sumpter et al., 2005). A double-stranded
segmented RNA virus, reovirus, induces IFN production mainly
through MDA5. However, the absence of both RIG-I and MDA5
completely abrogates this IFN production, suggesting that
both RIG-I and MDA5 are involved in the recognition of reovirus
(Kato et al., 2008; Loo et al., 2008). Mouse embryonic fibroblasts
(MEFs) derived from RIG-I/MDA5/ mice failed to produce
type I IFNs to any of the RNA viruses tested, indicating that
RIG-I and MDA5 are essential and sufficient for evoking type I
IFN production in response to RNA viruses.
RIG-I recognizes relatively short dsRNA (up to 1 kb), and the
presence of a 50 triphosphate end greatly enhances its type I
IFN-inducing activity (Figure 3). It has been postulated that 50
triphosphate ssRNA synthesized by in vitro transcription is a
RIG-I ligand (Hornung et al., 2006; Pichlmair et al., 2006).
However, recent studies have shown that T7 polymerase
commonly produces extended byproducts generating dsRNA
(Schlee et al., 2009; Schmidt et al., 2009). Chemically synthe-
sized 50 triphosphate ssRNA failed to stimulate RIG-I, indicating
that RNA needs to be double-stranded for activation of RIG-I.
Regarding a minimum length, the 19-mer or 21-mer dsRNACell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc. 809
Figure 3. Recognition of RNA Viruses by RLRs
RIG-I and MDA5 recognize different RNA viruses by detecting short dsRNAs
with 50 triphosphate ends and long dsRNAs, respectively. LGP2 functions as
a positive regulator in RIG-I-mediated and MDA5-mediated virus recognition.
Activation of RIG-I is positively and negatively regulated by ubiquitin ligases
TRIM25 and RNF125, respectively. RIG-I and MDA5 interact with IPS-1
through homophilic interactions between CARD domains. IPS-1 then activates
signaling cascades leading to the expression of type I IFN genes via EYA4,
TRAF3, NAP1/SINTBAD, TBK1/IKK-i, and IRF3/7. RLR signaling mediates
polyubiquitination of TRAF3, which is removed by a deubiquitinase, DUBA.
Simultaneously, IPS-1 signaling induces nuclear translocation of NF-kB via
TRADD and FADD and caspase-8/-10. A cleaved fragment of caspase-8/-10
is responsible for the activation of NF-kB.with a 50 triphosphate end is able to potently induce type I IFNs.
In contrast, a 50 triphosphate end is not always necessary, as
chemically synthesized dsRNAs with a 50 monophosphate end
or those without a 50 phosphate can potently activate RIG-I
(Takahasi et al., 2008; Kato et al., 2008). The amount of IFNs
produced by these RNAs is low compared to dsRNA with a 50810 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.triphosphate end. HCV genomic RNA has been screened for
RNA sequences that activate RIG-I. Poly(U)- or poly(A)-rich
sequences from the HCV RNA 30 untranslated region (UTR) are
responsible for RIG-I-mediated IFN production, based on
RNAs generated by in vitro transcription using T7 polymerase
(Saito et al., 2008). However, in vitro-transcribed RNAs with
low U/A content also potently activate RIG-I. Therefore, further
studies are required to clarify whether particular RNA sequences
are important for RIG-I-mediated recognition.
VSV produces dsRNA in infected cells (Kato et al., 2008).
Disruption of dsRNA among RNAs from VSV-infected cells
reduces the IFN-b-inducing activity, suggesting that the pres-
ence of dsRNA in VSV-infected cells is important for recognition
by RIG-I. Interestingly, the dsRNA fragments produced by VSV
infection are about 2.0–2.5 kb, and much shorter than the size
of the VSV genomic RNA. It has been reported that defective
interfering (DI) particles are generated in VSV-infected cells,
and that the sizes of DI particle dsRNAs are about 2.2 kb
(Pattnaik et al., 1995). Thus, the dsRNA generated during the
course of VSV replication may be derived from DI particles,
although further studies are needed to clarify the source of this
dsRNA. As DI particles are known to strongly induce type I
IFNs, RIG-I may play a role in detecting the presence of dsRNA
in DI particles. In contrast, it is difficult to detect dsRNA in cells
infected with influenza virus. Genomic RNA from influenza virus
lost its IFN-inducing activity after a phosphatase treatment that
removed the 50 triphosphate end. The sequences of the 50 and
30 ends of the viral RNA are partially complementary to each
other, and it has been suggested that a panhandle structure
can form (Hsu et al., 1987). Thus, it is tempting to speculate
that short panhandle dsRNAwith a 50 triphosphate is responsible
for recognition by RIG-I.
In contrast to RIG-I, MDA5 detects long dsRNA (more than
2 kb) such as poly I:C. MDA5/ mice show severely reduced
production of type I IFNs in response to poly I:C inoculation
in vivo, whereas their production of IL-12p40 is not impaired
(Kato et al., 2006). Shortening the length of the poly I:C by treat-
ment with a dsRNA-specific nuclease converts poly I:C from an
MDA5 ligand to a RIG-I ligand, indicating that long, but not short,
dsRNA is recognized by MDA5. EMCV produces high levels of
dsRNA in infected cells, and the 50 end of its genomic RNA is
covalently linked to a small protein, VPg. Investigation of RNA
from EMCV-stimulated cells has revealed that higher-order
structure RNA containing both dsRNA and ssRNA, but not
simple dsRNA as the replication intermediate, has MDA5-stimu-
lating activity (Pichlmair et al., 2009).
LGP2, the third member of the RLR family, lacks a CARD, and
in vitro studies have suggested that LGP2 functions as a negative
regulator of RIG-I and MDA5 responses by sequestering dsRNA
or inhibiting RIG-I conformational changes (Rothenfusser et al.,
2005; Saito et al., 2007; Yoneyama et al., 2005). However, the
generation of LGP2/ mice and mice with a point mutation,
D30A, that disrupts the ATPase activity of LGP2 revealed that
LGP2 positively regulates production of type I IFNs in response
to RNA viruses recognized by both RIG-I and MDA5 (Satoh
et al., 2010). Nevertheless, LGP2 is dispensable for type I IFN
production following transfection by synthetic RNAs. These
results suggest that LPS2 may modify viral RNA by removing
proteins from viral ribonucleoprotein (RNP) complexes or
unwinding complex RNA structures to facilitate MDA5-mediated
and RIG-I-mediated recognition of dsRNA.
RLRs contain a C-terminal regulatory domain, which is
responsible for the binding to dsRNAs. The recent solution of
RLR C-terminal regulatory domain structures revealed that the
C-terminal domains of LGP2 and RIG-I have a large basic
surface forming an RNA-binding loop (Cui et al., 2008; Takahasi
et al., 2008, 2009). The RIG-I and LGP2 C-terminal domains bind
to the termini of dsRNA. Although the MDA5 C-terminal domain
also has a large basic surface, it is extensively flat because of the
open conformation of the RNA-binding loop. Therefore, the
RNA-binding activity of MDA5 is much weaker than that of
RIG-I and LGP2. RLRs catalyze ATP via the DExD/H helicase
domain, and the ATPase activity is essential for RLRs to induce
type I IFN production. Although RIG-I has helicase activity, it is
not clear if the unwinding of dsRNA by RIG-I is required for trig-
gering the signaling pathway. RIG-I might change its conforma-
tion to expose the CARDs and dimerize by catalyzing ATP, or
alternatively, RIG-I may act as a translocase for dsRNA.
The RLR Signaling Pathways
The RIG-I conformation is known to be modulated by ubiquitina-
tion. TRIM25 and Riplet (also known as RNF135) act as E3 ubiq-
uitin ligases that mediate the K63-linked polyubiquitination of
RIG-I (Gack et al., 2007; Pichlmair et al., 2009). This modification
is required for the activation of RLR signaling. On the other hand,
K48-type polyubiquitination of RIG-I by RNF125 leads to RIG-I
degradation by the proteasome and inhibition of RIG-I signaling
(Arimoto et al., 2007).
The CARDs of RLRs are responsible for triggering signaling
cascades by interacting with the N-terminal CARD-containing
adaptor IFN-b-promoter stimulator 1 (IPS-1) (also known as
MAVS, CARDIF, or VISA) (Kawai and Akira, 2006) (Figure 3).
IPS-1 is localized on the mitochondrial membrane, and cleavage
of IPS-1 by an HCVNS3/4A protease, which dislodges it from the
mitochondrial membrane, results in abrogation of RLR signaling.
NLRX1 (also known as NOD9), an NLR family member, is local-
ized on the mitochondrial membrane and acts as an inhibitor of
IPS-1 signaling (Moore et al., 2008). However, another report
showed that NLRX1 is amitochondrial matrix protein responsible
for the generation of reactive oxygen species. Therefore, further
studies are required to clarify the role of NLRX1 in RLR signaling
(Arnoult et al., 2009). IPS-1 activates TRAF3 and TRADD
(Michallet et al., 2008). The downstream signaling molecules
for the expression of IFN-inducible genes are shared between
the IPS-1 and TRIF signaling pathways. The recently identified
protein Eyes absent 4 (EYA4) associates with IPS-1 and
NLRX1 and stimulates the expression of IFN-inducible genes in
response toDNAstimulation (Okabe et al., 2009). EYA4 is aphos-
phatase for both phosphotyrosine and phosphothreonine, and
the threonine phosphatase activity is essential for enhancing
IFN-b gene activation. Identification of molecules that are de-
phosphorylated by EYA4 will be important for understanding
the mechanism for how EYA4 regulates IFN responses.
In contrast to pDCs, autophagy negatively regulates IFN
responses in fibroblasts and cDCs by suppressing RLR signal-
ing (Jounai et al., 2007; Tal et al., 2009). In the absence ofautophagy-related proteins, such as ATG5 or ATG16L1, dam-
agedmitochondria accumulate together with IPS-1, and reactive
oxygen species associated with dysfunctional mitochondria are
responsible for the overproduction of type I IFNs.
Recognition of Cytoplasmic DNA
Although DNA with a CpG motif is sensed by TLR9, introduction
of dsDNA into cells evokes type I IFN responses in a TLR9-
independent manner. Right-handed spiral B-DNA, but not left-
handed Z-DNA, activates these responses (Ishii et al., 2006).
Although the sequence specificity has not been clearly
observed, synthetic poly (dA:dT) is more potent for induction of
IFN responses than poly (dI:dC) or poly (dG:dC). Transfection
of dsDNA leads to the activation of IRF3 via TBK1 and IKK-i,
but activation of NF-kB is barely detected in response to DNA.
It is believed that cytoplasmic DNA recognition is important for
the production of type I IFNs to infection with DNA viruses. Infec-
tion with intracellular bacteria such as Listeria monocytogenes
and Legionella pneumophila induces type I IFN production
in response to bacterial DNA in the cytoplasm (Stetson and
Medzhitov, 2006). In addition, the adjuvant effect of DNA
vaccines can be explained by TLR9-independent cytoplasmic
recognition of DNAs that activates the TBK1-IRF3-dependent
pathway (Ishii et al., 2008).
Two studies have shown that poly (dA:dT) can be transcribed
into dsRNA by polymerase III and that dsRNA is recognized in
a RIG-I-IPS-1-dependent manner in human cells or transformed
mouse MEFs (Figure 4) (Ablasser et al., 2009; Chiu et al., 2009;
Choi et al., 2009). However, primary DCs prepared from RIG-I-
deficient mice do not show a defect in IFN production, suggest-
ing that cytoplasmic DNAs are sensed in both a polymerase
III-RIG-I-dependent and -independent manner depending on
the species or cell types involved. A cytoplasmic DNA-binding
protein, DNA-dependent activator of IRF (DAI, also known as
Zbp1 or DLM1), interacts with TBK1 and activates type I IFN
responses (Takaoka et al., 2007). Nevertheless, Zbp1/ MEFs
are still capable of producing type I IFNs in response to cyto-
plasmic DNA, suggesting that cytoplasmic DNA is redundantly
recognized by as-yet unidentified receptors (Ishii et al., 2008).
Expression cloning of a gene inducing IFN-b promoter activa-
tion identified STING (also known as MITA, ERIS, or TMEM173),
a transmembrane protein expressed in the ER (Ishikawa and
Barber, 2008; Sun et al., 2009; Zhong et al., 2008). Cells and
mice lacking STING show impaired IFN production in response
to both RNA and DNA stimulation. STING associates with
a member of the translocon-associated protein (TRAP) complex
that is required for protein translocation across the ER in resting
cells. In response to transfection of dsDNA, STING translocates
from the ER to the Golgi apparatus and subsequently to cyto-
plasmic punctate structures where it colocalizes with TBK1
(Ishikawa et al., 2009). The exocyst complex is involved in secre-
tory vesicle sorting and is especially required for post-Golgi
transport to the plasma membrane. Sec5, a component of the
exocyst complex, colocalizes with STING. Activation of the
RalB GTPase promotes the assembly of TBK1 and Sec5, leading
to phosphorylation of Sec5 by TBK1. STING/ mice are highly
susceptible to HSV-1 or VSV infection, indicating a role for
STING in host defense against virus infection. Interestingly,Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc. 811
Figure 4. Recognition of Cytoplasmic DNA and IFN Production
Double-stranded DNA (dsDNA) accumulates in the cytoplasm after infection
by viruses or bacteria or through failure to process endogenous DNA. The
intracellular DNA is captured by HMGB1 and recognized by an unidentified
cytoplasmic receptor or DAI. Alternatively, dsDNA is transcribed into dsRNA
by polymerase III in a species- and cell type-specific manner. Generated
dsRNA is recognized by RIG-I and production of type I IFNs is induced.
Following DNA stimulation, an ER protein STING translocates from the ER to
the cytoplasmic punctate structure, where STING colocalizes with TBK1.autophagy-related gene 9a (ATG9a) colocalizes with STING
(Saitoh et al., 2009). Loss of ATG9a, but not another autoph-
agy-related gene (ATG7), greatly enhances the assembly of
STING with TBK1 in response to dsDNA, followed by increased
production of type I IFNs. Notably, the introduction of dsRNA did
not induce the translocation of STING; it will be interesting to
explore how STING regulates the IFN response to dsRNA. It
has been shown that TBK1 activation by RalB is involved in
cell transformation and tumor progression (Chien et al., 2006).
Furthermore, a recent study revealed that TBK1 is required for
KRAS-driven cancer formation, probably by activating the
NF-kB-induced antiapoptotic gene BCL-xL (Barbie et al.,
2009). Thus, TBK1 is a pleiotropic kinase involved in both innate
immunity and tumorigenesis.812 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.High-mobility group box (HMGB) proteins were originally iden-
tified as nuclear proteins with DNA-binding capacity. HMGB1 is
also known to be secreted in response to cell damage and
evokes inflammatory responses. Recently, HMGB proteins
present in the cytoplasm were found to act as the initial sensors
for cytoplasmic nucleic acids that lead to the activation of down-
stream receptors such as RLRs, TLRs, and unknownDNA recep-
tors (Yanai et al., 2009).
Although stimulation with TLR ligands alone does not lead to
activation of the inflammasome, the introduction of dsDNA
induces not only the production of pro-IL-b but also its cleavage
via caspase-1. Sensing of cytoplasmic DNA by absent-in-mela-
noma 2 (AIM2) activates the inflammasome via ASC and cas-
pase-1, leading to the production of IL-1b (see Review by
K. Schroder and J. Tschopp on page 821).
NLR- and CLR-Mediated Pathogen Recognition
The NLR family consists of cytoplasmic pathogen sensors that
are composed of a central nucleotide-binding domain and
C-terminal leucine-rich repeats (Inohara et al., 2005). The N-ter-
minal portions of most NLRs harbor protein-binding motifs, such
as CARDs, a pyrin domain, and a baculovirus inhibitor of
apoptosis protein repeat (BIR) domain. NLRs harboring a pyrin
domain or a BIR domain in their N terminus are not involved in
the transcriptional activation of inflammatory mediators and
are components of the inflammasome that regulates caspase-
1 activation. NOD1 and NOD2, which harbor CARDs in addition
to NOD and LRR domains, activate NF-kB via an adaptor, RIP2/
RICK. NOD1 and NOD2 induce transcriptional upregulation of
proinflammatory cytokine genes. NOD1 and NOD2 recognize
the structures of bacterial peptidoglycans, g-D-glutamyl-meso-
diaminopimelic acid (iE-DAP) and muramyl dipeptide (MDP),
respectively. As TLRs also recognize bacterial peptidoglycan
components, TLRs and NODs synergistically activate proinflam-
matory cytokine production. In addition to bacteria, a recent
study found that the expression of NOD2 is involved in
50-triphosphate RNA-induced type I IFN production and host
defense against respiratory syncytial virus infection (Sabbah
et al., 2009).
CLRs comprise a transmembrane receptor family character-
ized by the presence of a carbohydrate-binding domain. CLRs
recognize carbohydrates on microorganisms such as viruses,
bacteria, and fungi. CLRs either stimulate the production of
proinflammatory cytokines or inhibit TLR-mediated immune
complexes. The functions of CLRs are described in detail else-
where (Geijtenbeek and Gringhuis, 2009), and here we give just
a few examples of CLR-mediated microbial recognition. Dec-
tin-1 and dectin-2 are immunoreceptor tyrosine-based activa-
tion motif (ITAM)-coupled CLRs responsible for sensing
b-glucans from fungi. DCs activated by dectin-1 or dectin-2
are able to instruct T cells to confer protective immunity against
Candida albicans (Robinson et al., 2009). The macrophage
C-type lectin MINCLE (also known as Clec4e and Clecsf9)
senses infection by fungi such as Malassezia and Candida
(Yamasaki et al., 2009). In addition, MINCLE is responsible for
the detection of an endogenous protein, spliceosome-associ-
ated protein 130 (SAP130), which is a component of U2 snRNP
from necrotic host cells (Yamasaki et al., 2008). CLEC9A is
Figure 5. TLR-Inducible Proteins Regulate Inflammation
TLR signaling initially induces genes encoding TNF, Pro-IL-1b, IkBz, ATF3,
Zc3h12a, TTP, and so on. Proteins generated from these genes modulate
inflammatory protein expression by various mechanisms. IkBz positively regu-
lates transcription of genes including IL-6 and IL-12p40 by associating with
NF-kBp50. In contrast, ATF3 negatively regulates transcription of these genes
by activating HDAC, which suppresses gene expression by epigenetic regula-
tion. Zc3h12a acts as an RNase degrading IL-6 and IL-12p40 mRNA, whereas
TTP binds to TNF mRNA and recruits a deadenylase, which induces its degra-
dation through an exosome.expressed on CD8+ DCs in the spleen and also recognizes
necrotic cells for cross-priming. CLRs activate intracellular
signaling either via the ITAM domain of CLRs or via adaptors
harboring an ITAM domain, such as FcRg, DAP10, or DAP12.
The Syk tyrosine kinase is activated by ITAM-containing proteins
either directly or indirectly via ITAM-containing adaptors.
Engagement of Syk with CLRs activates MAP kinases, the
transcription factor NF-AT, and NF-kB through CARD9. As
a result, proinflammatory cytokines are produced. However,
the signaling mechanism for the production of proinflammatory
cytokines is not well understood.
Transcriptional Regulation of Inflammatory Mediators
Activation of PRR signaling pathways leads to the nuclear trans-
location of a set of transcription factors, including NF-kB, AP-1,
IRFs, andC/EBPb. These factors cooperatively regulate the tran-
scription of their target genes. Furthermore, remodeling of chro-
matin is important for controlling the transcriptional regulation of
a set of TLR-inducible genes (Ramirez-Carrozzi et al., 2006). In
addition, epigenetic controls of a set of TLR-inducible genes
are critical for induction of tolerance to LPS, a well-known
phenomenon rendering cells refractory to a second exposure
to LPS (Foster et al., 2007) (see Review by S.T. Smale on page
833 of this issue). Here, we focus on the TLR-inducible proteins
that modulate inflammatory responses. Besides cytokines, che-
mokines, and IFNs, TLR stimulation upregulates the expression
of hundreds of genes in macrophages. These genes are poten-
tially involved in antimicrobial defense (e.g., defensins, lipoca-
line), metabolic changes, and tissue repair (e.g., secretory leuko-
cyte peptidase inhibitor). Nevertheless, the functions of various
TLR-inducible genes remain largely unexplored. Some gene
products are associated with the positive and negative regula-
tion of inflammatory responses by controlling TLR-signaling
pathways. The genes immediately induced by TLR ligands
potentially regulate TLR signaling or responses after their
expression.
It is well known that the components of NF-kB are TLR-
induced genes that undergo positive feedback regulation by
NF-kB (Figure 5). In addition, IkBz and activating transcription
factor 3 (ATF3) are nuclear factors that are rapidly induced by
the TLRs (Gilchrist et al., 2006; Yamamoto et al., 2004). IkBz
harbors C-terminal ankyrin repeat motifs that bind to the
NF-kBp50 subunit, and expressed IkBz positively regulates the
induction of a set of genes including IL-6 and IL-12p40, which
are transcribed later. In contrast, ATF3 negatively regulates the
transcription of genes encoding IL-6 and IL-12p40 by increasing
histone deacetylase activity. Epigenetic changes can be regu-
lated by TLR-inducible proteins. Trimethyl-histone 3 lysine 27
demethylase, Jmjd3, is expressed in response to TLR stimula-
tion via NF-kB and is recruited to the transcription start sites of
LPS-inducible genes (De Santa et al., 2007). Given that Jmjd3
is recruited to the transcription start site of various LPS-inducible
genes, it may be responsible for the fine-tuning of LPS-induced
gene expression in macrophages (De Santa et al., 2009).
In response to TLR ligand stimulation, genes encoding
RNA-binding proteins with a CCCH-type zinc finger motif (Zf)
are rapidly induced. These proteins include Zc3h12a, Zc3h12c,
Zc3hav1, and tristetraprolin (TTP; also known as Zfp36)(Matsushita et al., 2009). TTP harbors two CCCH-type Zf
domains and associates with mRNA via AU-rich elements
present in the 30UTR, leading to removal of the poly(A) tail by
recruitment of a deadenylase (Carrick et al., 2004). The deadeny-
lated mRNAs traffic to exosomes where the RNA is degraded.
TTP is required to prevent the generation of autoimmune arthritis
in mice through controlling mRNAs encoding TNF. Zc3h12a and
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RNase domain (Matsushita et al., 2009). Zc3h12a is responsible
for degrading mRNAs for TLR-inducible proteins such as IL-6
and IL-12p40 in macrophages. Zc3h12a controls its target
mRNAs via the 30UTR independently of AU-rich elements; the
RNase activity is essential for mRNA degradation. Zc3h12a/
mice spontaneously develop a fatal inflammatory disease char-
acterized by highly elevated immunoglobulin levels and autoan-
tibody production. RLR signaling induces another gene encod-
ing a CCCH-type Zf protein, ZAP (also known as Zc3hav1).
ZAP contains four clusters of CCCH-type Zf domains and
directly binds to viral RNAs as well as exosomes where viral
RNA is degraded (Gao et al., 2002). ZAP overexpression is re-
ported to confer resistance against various viruses such as retro-
viruses and alphaviruses. Zcchc11 is a CCHC-type Zf domain-
containing RNA-binding protein with a nucleotidyltransferase
domain. A recent study found that Zcchc11 adds terminal
uridines to miR-26 family microRNAs, which target IL-6 mRNA
(Jones et al., 2009). Uridylated miR-26 fails to repress IL-6
mRNA, and Zcchc11 thereby potentiates IL-6 production in
response to TNF stimulation. It was reported that a set of mRNAs
rapidly expressed in response to TNF stimulation are critically
controlled through mRNA stability. These mRNAs tend to have
abundant AU-rich elements in their 30UTRs compared with
mRNAs expressed at later time points (Hao and Baltimore,
2009). Therefore, control of mRNA decay may be as important
as control of transcription in terms of the regulation of innate
immune responses.
TLR signaling induces the expression not only of protein-
coding mRNAs but also of noncoding RNAs (Guttman et al.,
2009). Some of the noncoding RNAs produce microRNAs
including miR-146a/b, miR-147, and miR-155 (Taganov et al.,
2006). These microRNAs interact with their target mRNAs and
fine-tune their expression to modulate the inflammatory
response. One of the best characterized microRNAs is
miR-155, which is rapidly induced in response to TLR ligands
and modulates innate and adaptive immune responses by
modulating the expression of multiple target mRNAs encoding
PU.1, IKK-i, SHIP1, and so on (Faraoni et al., 2009). A recent
report shows that miR-21 negatively regulates TLR4 signaling
by the tumor suppressor PDCD4, a protein required for NF-kB
activation (Sheedy et al., 2009).
PRR-Dependent Recognition of Self-Nucleotides
in Autoimmunity
Under physiological conditions, PRRs strictly discriminate self
and microbial components to prevent the development of auto-
immune disease. A hallmark of autoimmune disease is the
production of antibodies recognizing self-antigens. In human
autoimmune diseases such as systemic lupus erythematosus
(SLE), immune complexes are formed by autoantibodies and
deposited in the kidneys, causing glomerular nephritis. It has
been shown that serum type I IFN levels in SLE patients posi-
tively correlate with disease severity.
TLRs, especially TLR7 and TLR9, have been implicated in the
production of autoantibodies in various mouse models. Self-
nucleic acids released from damaged cells are rapidly degraded
by serum nucleases and do not encounter TLR7 or TLR9.
However, when self-nucleic acids interact with cellular proteins814 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.such as HMGB1, RNPs, antimicrobial peptides, and autoanti-
bodies, endocytosis of the resulting nucleic acid-protein
complexes is facilitated and induces TLR7- and TLR9-mediated
type I IFN production (Figure 2). For instance, HMGB1 interacts
with the receptor for advanced glycation end-products (RAGE)
on the cell surface, and HMGB1-DNA-containing immune
complexes released from damaged cells stimulate TLR9 and
RAGE, which cooperate to stimulate pDCs and B cells (Tian
et al., 2007). Endogenous RNA-protein complexes, such as U1
snRNP, can activate autoreactive B cells and DCs via TLR7
(Vollmer et al., 2005). Furthermore, nucleic acids bound to auto-
antibodies are endocytosed through B cell receptors and
FcgRIIA in B cells and DCs (Means et al., 2005; Viglianti et al.,
2003). Recognition of immune complexes by these receptors
leads to the activation of autoreactive B cells as well as the
production of type I IFNs, thus exacerbating the causes of auto-
immune diseases. Similarly, the cationic antimicrobial peptide
LL37 forms a complex with self-DNA or self-RNA, thereby facil-
itating endocytosis by pDCs and stimulating TLR-mediated IFN
responses (Ganguly et al., 2009; Lande et al., 2007). LL37 is
highly expressed in psoriasis skin lesions, and the production
of IFNs contributes to the pathogenesis of this disease. Taken
together these data show that the responses of nucleic acid-
sensing TLRs are positively regulated by endogenous proteins
that facilitate endocytosis of nucleic acids. Type I IFNs and
cytokines produced by the TLRs cause inflammation, and this
positive feedback mechanism is involved in the exacerbation
of autoimmune diseases.
The contributions of nucleic acid-sensing TLRs to autoimmu-
nity have been examined using mouse models that develop
autoimmune disease spontaneously. Duplication of the Tlr7
gene accounts for the autoimmune phenotypes associated
with Y chromosome-linked autoimmune accelerator (Yaa) mice
(Pisitkun et al., 2006; Subramanian et al., 2006). Reciprocally,
TLR7 deficiency in lupus-prone MRL lpr/lpr mice results in
reduced levels of autoantibodies recognizing RNA-containing
antigens and abrogation of disease (Christensen et al., 2006).
But the relationship between TLR9 and autoimmune disease
mouse models is complicated. Although CpG-DNA has been
used as an adjuvant to generate organ-specific autoimmune
disease in mouse models, the lack of TLR9 exacerbated the
severity of disease in the MRL lpr/lpr murine lupus model.
Although the TLR7 and TLR9 signaling pathways are indistin-
guishable, there is a clear difference in the roles of TLR7 and
TLR9 in the establishment of systemic autoimmune disease. A
mutation of amino acid D34 in UNC93B1 that changes its ability
to bind to TLR7 and TLR9 has been identified (Fukui et al., 2009).
The mutant UNC93B1 increases TLR7 responses but causes
hyporesponsiveness to TLR9. Given that TLR7 is important for
the generation of autoimmune disease models in mice, it is
possible that UNC93B1 suppresses RNA sensing by skewing
the response toward DNA.
Appropriate clearance of nucleic acids is essential for prevent-
ing autoimmune disease. DNase II is located in the lysosomes of
macrophages and is required for the degradation of DNA from
apoptotic cells. In the absence of DNase II, undigested DNA
accumulates in macrophages, and the resulting production of
IFN-b and TNF causes embryonic lethality (Kawane et al.,
2003). The type I IFNs are produced independently of TLR9, sug-
gesting that recognition of DNA by intracellular receptors is
responsible for the embryonic lethality of DNase II-deficient
mice (Okabe et al., 2005). Similarly, deficiency inDNase I, amajor
DNase present in serum, results in the generation of SLE-like
autoimmune disease in mice; a mutation in DNase I has been
identified in human SLE patients (Lee-Kirsch et al., 2007).
Aicardi-Goutie`res syndrome (AGS) is a human disorder charac-
terized by fatal encephalopathy owing to overproduction of
IFN-a. Recent studies have revealed that AGS is caused by
a mutation in 30 repair exonuclease 1 (Trex1) (Crow et al.,
2006). It has been shown that DNA derived from endogenous ret-
roelements accumulates in Trex1/ cells and stimulates the
induction of IFN-inducible genes (Stetson et al., 2008). In addi-
tion, mutations in components of RNase H2 are also involved
in AGS (Rice et al., 2009). Nucleic acid accumulation because
of a deficiency in these nucleases probably leads to recognition
of the nucleic acids by cytoplasmic PRRs resulting in the produc-
tion of type I IFNs. Interestingly, mutations in MDA5 that disrupt
its signaling ability correlate with resistance to type I diabetes,
although the mechanism for the contribution of MDA5 to this
disease remains unclear (Nejentsev et al., 2009). Future studies
will clarify how cytoplasmic PRRs contribute to the generation
of autoimmune disease.
PRR Activation in Acute and Chronic Inflammation
PRRs recognizing non-nucleic acid ligands are also involved in
various inflammatory and autoimmune diseases. It is well known
that activation of TLR signaling by bacterial components leads to
acute inflammation, culminating in septic shock in some cases.
TLR ligands also are commonly used as adjuvants to generate
organ-specific autoimmune disease models in mice for arthritis
or encephalitis, for example.
A mutation in NOD2 that generates a truncated form of the
protein is frequently found in patients with Crohn’s disease, an
inflammatory bowel disorder (Cho, 2008). This disease may arise
through impairment of proper responses to intestinal bacteria
and aberrant bacterial growth causing increased inflammatory
responses in the intestine. Mutations in the autophagy-related
gene ATG16L1 are also implicated in susceptibility to Crohn’s
disease. In the absence of ATG16L1 in mice, overactivation of
the inflammasome occurs, and increased production of IL-1b
and IL-18 contributes to inflammation in the intestine (Saitoh
et al., 2008). Furthermore, ATG16L1 is critical for the normal
function of intestinal Paneth cells (Cadwell et al., 2008).
Lack of negative regulators for TLRs can cause autoimmune
disease based on various mouse models. Loss of the protein
tyrosine phosphatase SHP1 in mice induced by N-ethyl-N-nitro-
sourea (ENU) mutagenesis leads to the generation of inflamma-
tory lesions together with overactivation of macrophages in
response to TLR stimulation (Croker et al., 2008). The inflamma-
tion is suppressed by loss of MyD88, suggesting that microbe-
induced hyperactivation of TLR signaling is responsible for the
generation of this inflammatory disease. A20 is a protein with
dual enzyme domains, comprising an E3 ubiquitin ligase and
a deubiquitinase that removes K63-linked polyubiquitin chains.
A20 negatively regulates NF-kB activation downstream of
TLR2 and NOD1/NOD2 (Boone et al., 2004; Hitotsumatsuet al., 2008). In the absence of A20, mice develop multiorgan
inflammatory disorders that lead to premature death. Another
example of a TLR negative regulator is TANK. Generation of
mice lacking TANK revealed that TANK is critical for controlling
TLR signaling in macrophages as well as antigen receptor
signaling in B cells, by inhibiting the activation of TRAF6
(Kawagoe et al., 2009). TANK/ mice spontaneously develop
autoimmune glomerular nephritis depending on the presence
of MyD88 or IL-6. These results suggest that aberrant activation
of innate immune cells and B cells is responsible for the genera-
tion of autoimmune diseases resembling human SLE. These
studies indicate that negative regulation of PRRs, especially
TLR signaling, is important for coordinated innate immune
responses.
It is well known that TLR-dependent inflammation contributes
significantly to the pathogenesis of ischemia-reperfusion
myocardial injury. Mice lacking TLR2, TLR4, or MyD88 show
reduced infarcted regions in response to cardiac as well as cere-
bral ischemic-reperfusion injury (Arumugam et al., 2009). In
contrast, pretreatment of mice with TLR ligands such as LPS
induces tolerance and reduces the infarct size after ischemic-
reperfusion injury. The effects of TLR agonists may be explained
by tolerance induction through initial stimulation of TLRs. TLRs
are similarly involved in the pathogenesis of cerebral ischemia-
reperfusion injury models. Other extensive studies have shown
that TLR2 and TLR4 are required for the production of athero-
sclerotic lesions in mice with hyperlipidemia.
Given that TLR2 and TLR4 are clearly responsible for the
severity of inflammation induced by nonmicrobial agents, it has
been postulated that endogenous molecules directly activate
these TLRs. It has been shown that HMGB1 released from
necrotic cells stimulates TLR2 and TLR4 to induce the produc-
tion of proinflammatory cytokines (Lotze and Tracey, 2005).
Furthermore, heat shock proteins (HSPs) such as HSP60,
HSP70, gp96, and HSP22 are also reported to be recognized
by TLR2 and TLR4 (Asea et al., 2002; Ohashi et al., 2000; Roelofs
et al., 2006; Warger et al., 2006). However, most studies
describing endogenous protein ligands for TLR2 and TLR4
used recombinant proteins generated in an Escherichia coli
expression system. We need to interpret the data carefully as it
is very difficult to completely eliminate the possibility of contam-
ination by E. coli components that stimulate TLRs. Nevertheless,
it is apparent that these TLRs contribute to inflammatory
diseases caused by nonmicrobial agents. Further studies will
uncover how these agents activate TLR-induced inflammation.
Future Perspectives
In this Review, we have discussed how the sensing of pathogens
and cellular components by PRRs triggers inflammation and its
consequences. The cellular mechanisms for individual PRRs to
induce pleiotropic outcomes are complex, and we are far from
predicting the entire immune response, which is mediated by
crosstalk among the various PRRs. Furthermore, we do not
know much about the dynamic regulation of immune cell activa-
tion or behavior. Investigations into how inflammation is physio-
logically controlled to cause appropriate outcomes are in their
infancy. We believe that one direction for future research is to
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in vivo by using imaging techniques, as immune cell activation is
differentially regulated depending on the cell type involved. A
second important approach is to integrate accumulating knowl-
edge using a systems biology strategy. Indeed, there have been
several attempts to incorporate systems biology into immu-
nology research. Using a systems biology approach, Aderem
and colleagues identified ATF3 and C/EBPg as a suppressor
and amplifier of TLR-mediated gene expression, respectively
(Gilchrist et al., 2006; Litvak et al., 2009). There have also been
attempts to comprehensively understand the transcription
networks activated in response to PRR stimulation in DCs.
Recently, Regev and coauthors selected 125 transcription regu-
lators involved in TLR-mediated gene expression based on gene
expression profiles and constructed a network model by knock-
ing down each of them in turn (Amit et al., 2009). However,
multiple PRRs are activated simultaneously in the course of
microbial infection. Thus, the dynamic changes in transcriptional
networks activated in response to inflammatory stimuli are likely
to be highly complex. In the future, the merging of imaging,
systems biology, and immunology will uncover the dynamics of
PRR-mediated inflammatory responses and their role in autoim-
mune disease.ACKNOWLEDGMENTS
We thank D.M. Standley for critical reading of this manuscript and E. Kamada
for secretarial assistance. This work was supported by the Special Coordina-
tion Funds of the JapaneseMinistry of Education, Culture, Sports, Science and
Technology, the 21st Century Center of Excellence Program of Japan, and the
NIH (P01 AI070167).REFERENCES
Ablasser, A., Bauernfeind, F., Hartmann, G., Latz, E., Fitzgerald, K.A., and
Hornung, V. (2009). RIG-I-dependent sensing of poly(dA:dT) through the
induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immu-
nol. 10, 1065–1072.
Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and
innate immunity. Cell 124, 783–801.
Amit, I., Garber, M., Chevrier, N., Leite, A.P., Donner, Y., Eisenhaure, T.,
Guttman, M., Grenier, J.K., Li, W., Zuk, O., et al. (2009). Unbiased reconstruc-
tion of a mammalian transcriptional network mediating pathogen responses.
Science 326, 257–263.
Arimoto, K., Takahashi, H., Hishiki, T., Konishi, H., Fujita, T., and Shimotohno,
K. (2007). Negative regulation of the RIG-I signaling by the ubiquitin ligase
RNF125. Proc. Natl. Acad. Sci. USA 104, 7500–7505.
Arnoult, D., Soares, F., Tattoli, I., Castanier, C., Philpott, D.J., and Girardin,
S.E. (2009). An N-terminal addressing sequence targets NLRX1 to the mito-
chondrial matrix. J. Cell Sci. 122, 3161–3168.
Arumugam, T.V., Okun, E., Tang, S.C., Thundyil, J., Taylor, S.M., and
Woodruff, T.M. (2009). Toll-like receptors in ischemia-reperfusion injury.
Shock 32, 4–16.
Asagiri, M., Hirai, T., Kunigami, T., Kamano, S., Gober, H.J., Okamoto, K.,
Nishikawa, K., Latz, E., Golenbock, D.T., Aoki, K., et al. (2008). Cathepsin
K-dependent toll-like receptor 9 signaling revealed in experimental arthritis.
Science 319, 624–627.
Asea, A., Rehli, M., Kabingu, E., Boch, J.A., Bare, O., Auron, P.E., Stevenson,
M.A., and Calderwood, S.K. (2002). Novel signal transduction pathway utilized
by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol.
Chem. 277, 15028–15034.816 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.Barbalat, R., Lau, L., Locksley, R.M., and Barton, G.M. (2009). Toll-like
receptor 2 on inflammatory monocytes induces type I interferon in response
to viral but not bacterial ligands. Nat. Immunol. 10, 1200–1207.
Barbie, D.A., Tamayo, P., Boehm, J.S., Kim, S.Y., Moody, S.E., Dunn, I.F.,
Schinzel, A.C., Sandy, P., Meylan, E., Scholl, C., et al. (2009). Systematic
RNA interference reveals that oncogenic KRAS-driven cancers require
TBK1. Nature 462, 108–112.
Barton, G.M., and Kagan, J.C. (2009). A cell biological view of Toll-like receptor
function: regulation through compartmentalization. Nat. Rev. Immunol. 9,
535–542.
Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du,
X., and Hoebe, K. (2006). Genetic analysis of host resistance: Toll-like receptor
signaling and immunity at large. Annu. Rev. Immunol. 24, 353–389.
Boone, D.L., Turer, E.E., Lee, E.G., Ahmad, R.C., Wheeler, M.T., Tsui, C., Hur-
ley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004). The ubiquitin-modi-
fying enzyme A20 is required for termination of Toll-like receptor responses.
Nat. Immunol. 5, 1052–1060.
Cadwell, K., Liu, J.Y., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J.K., Kishi, C.,
Kc, W., Carrero, J.A., Hunt, S., et al. (2008). A key role for autophagy and the
autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature
456, 259–263.
Carrick, D.M., Lai, W.S., and Blackshear, P.J. (2004). The tandem CCCH zinc
finger protein tristetraprolin and its relevance to cytokine mRNA turnover and
arthritis. Arthritis Res. Ther. 6, 248–264.
Carty, M., Goodbody, R., Schroder, M., Stack, J., Moynagh, P.N., and Bowie,
A.G. (2006). The human adaptor SARM negatively regulates adaptor protein
TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7, 1074–1081.
Chien, Y., Kim, S., Bumeister, R., Loo, Y.M., Kwon, S.W., Johnson, C.L., Bala-
kireva, M.G., Romeo, Y., Kopelovich, L., Gale, M., Jr., et al. (2006). RalB
GTPase-mediated activation of the IkappaB family kinase TBK1 couples
innate immune signaling to tumor cell survival. Cell 127, 157–170.
Chiu, Y.H., Macmillan, J.B., and Chen, Z.J. (2009). RNA polymerase III detects
cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell
138, 576–591.
Cho, J.H. (2008). The genetics and immunopathogenesis of inflammatory
bowel disease. Nat. Rev. Immunol. 8, 458–466.
Choe, J., Kelker, M.S., and Wilson, I.A. (2005). Crystal structure of human toll-
like receptor 3 (TLR3) ectodomain. Science 309, 581–585.
Choi, M.K., Wang, Z., Ban, T., Yanai, H., Lu, Y., Koshiba, R., Nakaima, Y.,
Hangai, S., Savitsky, D., Nakasato, M., et al. (2009). A selective contribution
of the RIG-I-like receptor pathway to type I interferon responses activated
by cytosolic DNA. Proc. Natl. Acad. Sci. USA 106, 17870–17875.
Christensen, S.R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R.A., and
Shlomchik, M.J. (2006). Toll-like receptor 7 and TLR9 dictate autoantibody
specificity and have opposing inflammatory and regulatory roles in a murine
model of lupus. Immunity 25, 417–428.
Coban, C., Ishii, K.J., Kawai, T., Hemmi, H., Sato, S., Uematsu, S., Yamamoto,
M., Takeuchi, O., Itagaki, S., Kumar, N., et al. (2005). Toll-like receptor 9 medi-
ates innate immune activation by the malaria pigment hemozoin. J. Exp. Med.
201, 19–25.
Coban, C., Igari, Y., Yagi, M., Reimer, T., Koyama, S., Aoshi, T., Ohata, K., Tsu-
kui, T., Takeshita, F., Sakurai, K., et al. (2010). Immunogenicity of whole para-
site vaccines against plasmodium falciparum involves malarial hemozoin and
host TLR9. Cell Host Microbe 7, 50–61.
Croker, B.A., Lawson, B.R., Rutschmann, S., Berger, M., Eidenschenk, C.,
Blasius, A.L., Moresco, E.M., Sovath, S., Cengia, L., Shultz, L.D., et al.
(2008). Inflammation and autoimmunity caused by a SHP1 mutation depend
on IL-1, MyD88, and a microbial trigger. Proc. Natl. Acad. Sci. USA 105,
15028–15033.
Crow, Y.J., Hayward, B.E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black,
D.N., van Bokhoven, H., Brunner, H.G., Hamel, B.C., et al. (2006). Mutations
in the gene encoding the 30-50 DNA exonuclease TREX1 cause Aicardi-Gou-
tieres syndrome at the AGS1 locus. Nat. Genet. 38, 917–920.
Cui, S., Eisenacher, K., Kirchhofer, A., Brzozka, K., Lammens, A., Lammens,
K., Fujita, T., Conzelmann, K.K., Krug, A., and Hopfner, K.P. (2008). The
C-terminal regulatory domain is the RNA 50-triphosphate sensor of RIG-I.
Mol. Cell 29, 169–179.
De Santa, F., Totaro, M.G., Prosperini, E., Notarbartolo, S., Testa, G., and Na-
toli, G. (2007). The histone H3 lysine-27 demethylase Jmjd3 links inflammation
to inhibition of polycomb-mediated gene silencing. Cell 130, 1083–1094.
De Santa, F., Narang, V., Yap, Z.H., Tusi, B.K., Burgold, T., Austenaa, L., Bucci,
G., Caganova, M., Notarbartolo, S., Casola, S., et al. (2009). Jmjd3 contributes
to the control of gene expression in LPS-activatedmacrophages. EMBO J. 28,
3341–3352.
Ermolaeva, M.A., Michallet, M.C., Papadopoulou, N., Utermohlen, O., Krani-
dioti, K., Kollias, G., Tschopp, J., and Pasparakis, M. (2008). Function of
TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent
inflammatory responses. Nat. Immunol. 9, 1037–1046.
Ewald, S.E., Lee, B.L., Lau, L., Wickliffe, K.E., Shi, G.P., Chapman, H.A., and
Barton, G.M. (2008). The ectodomain of Toll-like receptor 9 is cleaved to
generate a functional receptor. Nature 456, 658–662.
Faraoni, I., Antonetti, F.R., Cardone, J., and Bonmassar, E. (2009). miR-155
gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 1792,
497–505.
Foster, S.L., Hargreaves, D.C., and Medzhitov, R. (2007). Gene-specific
control of inflammation by TLR-induced chromatin modifications. Nature
447, 972–978.
Fukui, R., Saitoh, S., Matsumoto, F., Kozuka-Hata, H., Oyama, M., Tabeta, K.,
Beutler, B., and Miyake, K. (2009). Unc93B1 biases Toll-like receptor
responses to nucleic acid in dendritic cells toward DNA- but against RNA-
sensing. J. Exp. Med. 206, 1339–1350.
Gack, M.U., Shin, Y.C., Joo, C.H., Urano, T., Liang, C., Sun, L., Takeuchi, O.,
Akira, S., Chen, Z., Inoue, S., and Jung, J.U. (2007). TRIM25 RING-finger E3
ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446,
916–920.
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V.,
Homey, B., Barrat, F.J., Zal, T., and Gilliet, M. (2009). Self-RNA-antimicrobial
peptide complexes activate human dendritic cells through TLR7 and TLR8.
J. Exp. Med. 206, 1983–1994.
Gao, G., Guo, X., and Goff, S.P. (2002). Inhibition of retroviral RNA production
by ZAP, a CCCH-type zinc finger protein. Science 297, 1703–1706.
Geijtenbeek, T.B., and Gringhuis, S.I. (2009). Signalling through C-type lectin
receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465–479.
Gilchrist, M., Thorsson, V., Li, B., Rust, A.G., Korb, M., Roach, J.C., Kennedy,
K., Hai, T., Bolouri, H., and Aderem, A. (2006). Systems biology approaches
identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441,
173–178.
Guo, B., and Cheng, G. (2007). Modulation of the interferon antiviral response
by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282, 11817–11826.
Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M.,
Zuk, O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals
over a thousand highly conserved large non-coding RNAs in mammals. Nature
458, 223–227.
Haas, T., Metzger, J., Schmitz, F., Heit, A., Muller, T., Latz, E., and Wagner, H.
(2008). The DNA sugar backbone 20 deoxyribose determines toll-like receptor
9 activation. Immunity 28, 315–323.
Hacker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.C.,Wang, G.G.,
Kamps, M.P., Raz, E., Wagner, H., Hacker, G., et al. (2006). Specificity in Toll-
like receptor signalling through distinct effector functions of TRAF3 and
TRAF6. Nature 439, 204–207.
Hao, S., and Baltimore, D. (2009). The stability of mRNA influences the
temporal order of the induction of genes encoding inflammatory molecules.
Nat. Immunol. 10, 281–288.
Hitotsumatsu, O., Ahmad, R.C., Tavares, R., Wang, M., Philpott, D., Turer,
E.E., Lee, B.L., Shiffin, N., Advincula, R., Malynn, B.A., et al. (2008). The ubiq-uitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain
containing 2-triggered signals. Immunity 28, 381–390.
Honda, K., Takaoka, A., and Taniguchi, T. (2006). Type I interferon [corrected]
gene induction by the interferon regulatory factor family of transcription
factors. Immunity 25, 349–360.
Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H., Poeck, H.,
Akira, S., Conzelmann, K.K., Schlee, M., et al. (2006). 50-Triphosphate RNA
is the ligand for RIG-I. Science 314, 994–997.
Hsu, M.T., Parvin, J.D., Gupta, S., Krystal, M., and Palese, P. (1987). Genomic
RNAs of influenza viruses are held in a circular conformation in virions and
in infected cells by a terminal panhandle. Proc. Natl. Acad. Sci. USA 84,
8140–8144.
Imai, Y., Kuba, K., Neely, G.G., Yaghubian-Malhami, R., Perkmann, T., van
Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y.H., Wang, H., et al. (2008).
Identification of oxidative stress and Toll-like receptor 4 signaling as a key
pathway of acute lung injury. Cell 133, 235–249.
Inohara, Chamaillard, McDonald, C., and Nunez, G. (2005). NOD-LRR
proteins: role in host-microbial interactions and inflammatory disease. Annu.
Rev. Biochem. 74, 355–383.
Ishii, K.J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig,
H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2006). A Toll-like receptor-indepen-
dent antiviral response induced by double-stranded B-form DNA. Nat.
Immunol. 7, 40–48.
Ishii, K.J., Kawagoe, T., Koyama, S., Matsui, K., Kumar, H., Kawai, T.,
Uematsu, S., Takeuchi, O., Takeshita, F., Coban, C., and Akira, S. (2008).
TANK-binding kinase-1 delineates innate and adaptive immune responses
to DNA vaccines. Nature 451, 725–729.
Ishikawa, H., and Barber, G.N. (2008). STING is an endoplasmic reticulum
adaptor that facilitates innate immune signalling. Nature 455, 674–678.
Ishikawa, H., Ma, Z., and Barber, G.N. (2009). STING regulates intracellular
DNA-mediated, type I interferon-dependent innate immunity. Nature 461,
788–792.
Jin, M.S., Kim, S.E., Heo, J.Y., Lee, M.E., Kim, H.M., Paik, S.G., Lee, H., and
Lee, J.O. (2007). Crystal structure of the TLR1-TLR2 heterodimer induced by
binding of a tri-acylated lipopeptide. Cell 130, 1071–1082.
Jones, M.R., Quinton, L.J., Blahna, M.T., Neilson, J.R., Fu, S., Ivanov, A.R.,
Wolf, D.A., and Mizgerd, J.P. (2009). Zcchc11-dependent uridylation of micro-
RNA directs cytokine expression. Nat. Cell Biol. 11, 1157–1163.
Jounai, N., Takeshita, F., Kobiyama, K., Sawano, A., Miyawaki, A., Xin, K.Q.,
Ishii, K.J., Kawai, T., Akira, S., Suzuki, K., and Okuda, K. (2007). The Atg5
Atg12 conjugate associates with innate antiviral immune responses. Proc.
Natl. Acad. Sci. USA 104, 14050–14055.
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K.,
Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., and Akira, S. (2005). Cell
type-specific involvement of RIG-I in antiviral response. Immunity 23, 19–28.
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K.,
Uematsu, S., Jung, A., Kawai, T., Ishii, K.J., et al. (2006). Differential roles of
MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441,
101–105.
Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K.,
Hiiragi, A., Dermody, T.S., Fujita, T., and Akira, S. (2008). Length-dependent
recognition of double-stranded ribonucleic acids by retinoic acid-inducible
gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205,
1601–1610.
Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Sai-
toh, T., Kawai, T., Takeuchi, O., and Akira, S. (2008). Sequential control of Toll-
like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9,
684–691.
Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T.,
and Akira, S. (2009). TANK is a negative regulator of Toll-like receptor signaling
and is critical for the prevention of autoimmune nephritis. Nat. Immunol. 10,
965–972.Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc. 817
Kawai, T., and Akira, S. (2006). Innate immune recognition of viral infection.
Nat. Immunol. 7, 131–137.
Kawane, K., Fukuyama, H., Yoshida, H., Nagase, H., Ohsawa, Y., Uchiyama,
Y., Okada, K., Iida, T., and Nagata, S. (2003). Impaired thymic development
in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 4,
138–144.
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O’Rourke, K.M.,
Eby, M., Pietras, E., Cheng, G., Bazan, J.F., et al. (2007). DUBA: a deubiquiti-
nase that regulates type I interferon production. Science 318, 1628–1632.
Kim, Y.M., Brinkmann, M.M., Paquet, M.E., and Ploegh, H.L. (2008). UNC93B1
delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452,
234–238.
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.H., Homey, B.,
Cao, W., Wang, Y.H., Su, B., Nestle, F.O., et al. (2007). Plasmacytoid dendritic
cells sense self-DNA coupledwith antimicrobial peptide. Nature 449, 564–569.
Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N., and Iwasaki, A. (2007).
Autophagy-dependent viral recognition by plasmacytoid dendritic cells.
Science 315, 1398–1401.
Lee-Kirsch, M.A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.A.,
de Silva, U., Bailey, S.L., Witte, T., Vyse, T.J., et al. (2007). Mutations in the
gene encoding the 30-50 DNA exonuclease TREX1 are associated with
systemic lupus erythematosus. Nat. Genet. 39, 1065–1067.
Litvak, V., Ramsey, S.A., Rust, A.G., Zak, D.E., Kennedy, K.A., Lampano, A.E.,
Nykter, M., Shmulevich, I., and Aderem, A. (2009). Function of C/EBPdelta in
a regulatory circuit that discriminates between transient and persistent
TLR4-induced signals. Nat. Immunol. 10, 437–443.
Liu, L., Botos, I., Wang, Y., Leonard, J.N., Shiloach, J., Segal, D.M., and
Davies, D.R. (2008). Structural basis of toll-like receptor 3 signaling with
double-stranded RNA. Science 320, 379–381.
Loo, Y.M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-
Sobrido, L., Akira, S., Gill, M.A., Garcia-Sastre, A., Katze, M.G., and Gale,
M., Jr. (2008). Distinct RIG-I and MDA5 signaling by RNA viruses in innate
immunity. J. Virol. 82, 335–345.
Lotze, M.T., and Tracey, K.J. (2005). High-mobility group box 1 protein
(HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5,
331–342.
Mancuso, G., Gambuzza, M., Midiri, A., Biondo, C., Papasergi, S., Akira, S.,
Teti, G., and Beninati, C. (2009). Bacterial recognition by TLR7 in the lyso-
somes of conventional dendritic cells. Nat. Immunol. 10, 587–594.
Matsumoto, F., Saitoh, S., Fukui, R., Kobayashi, T., Tanimura, N., Konno, K.,
Kusumoto, Y., Akashi-Takamura, S., and Miyake, K. (2008). Cathepsins are
required for Toll-like receptor 9 responses. Biochem. Biophys. Res. Commun.
367, 693–699.
Matsushita, K., Takeuchi, O., Standley, D.M., Kumagai, Y., Kawagoe, T.,
Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., and Akira, S.
(2009). Zc3h12a is an RNase essential for controlling immune responses by
regulating mRNA decay. Nature 458, 1185–1190.
Means, T.K., Latz, E., Hayashi, F., Murali, M.R., Golenbock, D.T., and Luster,
A.D. (2005). Human lupus autoantibody-DNA complexes activate DCs through
cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407–417.
Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature
454, 428–435.
Michallet, M.C., Meylan, E., Ermolaeva, M.A., Vazquez, J., Rebsamen, M.,
Curran, J., Poeck, H., Bscheider, M., Hartmann, G., Konig, M., et al. (2008).
TRADD protein is an essential component of the RIG-like helicase antiviral
pathway. Immunity 28, 651–661.
Moore, C.B., Bergstralh, D.T., Duncan, J.A., Lei, Y., Morrison, T.E., Zimmer-
mann, A.G., Accavitti-Loper, M.A., Madden, V.J., Sun, L., Ye, Z., et al.
(2008). NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451,
573–577.
Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M.,
Takayanagi, H., Ohba, Y., Taniguchi, T., and Honda, K. (2006). Evidence for
licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor818 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.by MyD88 in Toll-like receptor-dependent gene induction program. Proc.
Natl. Acad. Sci. USA 103, 15136–15141.
Nejentsev, S., Walker, N., Riches, D., Egholm, M., and Todd, J.A. (2009). Rare
variants of IFIH1, a gene implicated in antiviral responses, protect against type
1 diabetes. Science 324, 387–389.
Oganesyan, G., Saha, S.K., Guo, B., He, J.Q., Shahangian, A., Zarnegar, B.,
Perry, A., and Cheng, G. (2006). Critical role of TRAF3 in the Toll-like
receptor-dependent and -independent antiviral response. Nature 439,
208–211.
Ohashi, K., Burkart, V., Flohe, S., and Kolb, H. (2000). Cutting edge: heat shock
protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.
J. Immunol. 164, 558–561.
Okabe, Y., Kawane, K., Akira, S., Taniguchi, T., and Nagata, S. (2005). Toll-like
receptor-independent gene induction program activated by mammalian DNA
escaped from apoptotic DNA degradation. J. Exp. Med. 202, 1333–1339.
Okabe, Y., Sano, T., and Nagata, S. (2009). Regulation of the innate immune
response by threonine-phosphatase of Eyes absent. Nature 460, 520–524.
Palsson-McDermott, E.M., Doyle, S.L., McGettrick, A.F., Hardy, M., Husebye,
H., Banahan, K., Gong,M., Golenbock, D., Espevik, T., andO’Neill, L.A. (2009).
TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor
MyD88-independent TLR4 pathway. Nat. Immunol. 10, 579–586.
Park, B., Brinkmann,M.M., Spooner, E., Lee, C.C., Kim, Y.M., and Ploegh, H.L.
(2008). Proteolytic cleavage in an endolysosomal compartment is required for
activation of Toll-like receptor 9. Nat. Immunol. 9, 1407–1414.
Park, B.S., Song, D.H., Kim, H.M., Choi, B.S., Lee, H., and Lee, J.O. (2009). The
structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
Nature 458, 1191–1195.
Parroche, P., Lauw, F.N., Goutagny, N., Latz, E., Monks, B.G., Visintin, A., Hal-
men, K.A., Lamphier, M., Olivier, M., Bartholomeu, D.C., et al. (2007). Malaria
hemozoin is immunologically inert but radically enhances innate responses by
presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104,
1919–1924.
Pattnaik, A.K., Ball, L.A., LeGrone, A., and Wertz, G.W. (1995). The termini of
VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication,
and budding to generate infectious particles. Virology 206, 760–764.
Pichlmair, A., Schulz, O., Tan, C.P., Naslund, T.I., Liljestrom, P., Weber, F., and
Reis e Sousa, C. (2006). RIG-I-mediated antiviral responses to single-stranded
RNA bearing 50-phosphates. Science 314, 997–1001.
Pichlmair, A., Schulz, O., Tan, C.P., Rehwinkel, J., Kato, H., Takeuchi, O.,
Akira, S., Way, M., Schiavo, G., and Reis e Sousa, C. (2009). Activation of
MDA5 requires higher-order RNA structures generated during virus infection.
J. Virol. 83, 10761–10769.
Pisitkun, P., Deane, J.A., Difilippantonio, M.J., Tarasenko, T., Satterthwaite,
A.B., and Bolland, S. (2006). Autoreactive B cell responses to RNA-related
antigens due to TLR7 gene duplication. Science 312, 1669–1672.
Pobezinskaya, Y.L., Kim, Y.S., Choksi, S., Morgan, M.J., Li, T., Liu, C., and Liu,
Z. (2008). The function of TRADD in signaling through tumor necrosis factor
receptor 1 and TRIF-dependent Toll-like receptors. Nat. Immunol. 9,
1047–1054.
Ramirez-Carrozzi, V.R., Nazarian, A.A., Li, C.C., Gore, S.L., Sridharan, R.,
Imbalzano, A.N., and Smale, S.T. (2006). Selective and antagonistic functions
of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an
inflammatory response. Genes Dev. 20, 282–296.
Rice, G.I., Bond, J., Asipu, A., Brunette, R.L., Manfield, I.W., Carr, I.M., Fuller,
J.C., Jackson, R.M., Lamb, T., Briggs, T.A., et al. (2009). Mutations involved in
Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate
immune response. Nat. Genet. 41, 829–832.
Robinson, M.J., Osorio, F., Rosas, M., Freitas, R.P., Schweighoffer, E., Gross,
O., Verbeek, J.S., Ruland, J., Tybulewicz, V., Brown, G.D., et al. (2009). Dectin-
2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to
fungal infection. J. Exp. Med. 206, 2037–2051.
Roelofs, M.F., Boelens,W.C., Joosten, L.A., Abdollahi-Roodsaz, S., Geurts, J.,
Wunderink, L.U., Schreurs, B.W., van den Berg, W.B., and Radstake, T.R.
(2006). Identification of small heat shock protein B8 (HSP22) as a novel TLR4
ligand and potential involvement in the pathogenesis of rheumatoid arthritis.
J. Immunol. 176, 7021–7027.
Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B.G., Schoe-
nemeyer, A., Yamamoto, M., Akira, S., and Fitzgerald, K.A. (2005). The RNA
helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic
acid-inducible gene-I. J. Immunol. 175, 5260–5268.
Ryzhakov, G., and Randow, F. (2007). SINTBAD, a novel component of innate
antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK.
EMBO J. 26, 3180–3190.
Sabbah, A., Chang, T.H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P.H.,
Xiang, Y., and Bose, S. (2009). Activation of innate immune antiviral responses
by Nod2. Nat. Immunol. 10, 1073–1080.
Saito, T., Hirai, R., Loo, Y.M., Owen, D., Johnson, C.L., Sinha, S.C., Akira, S.,
Fujita, T., and Gale, M., Jr. (2007). Regulation of innate antiviral defenses
through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad.
Sci. USA 104, 582–587.
Saito, T., Owen, D.M., Jiang, F., Marcotrigiano, J., and Gale, M., Jr. (2008).
Innate immunity induced by composition-dependent RIG-I recognition of
hepatitis C virus RNA. Nature 454, 523–527.
Saitoh, T., Fujita, N., Jang,M.H., Uematsu, S., Yang, B.G., Satoh, T., Omori, H.,
Noda, T., Yamamoto, N., Komatsu, M., et al. (2008). Loss of the autophagy
protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature
456, 264–268.
Saitoh, T., Fujita, N., Hayashi, T., Takahara, K., Satoh, T., Lee, H., Matsunaga,
K., Kageyama, S., Omori, H., Noda, T., et al. (2009). Atg9a controls dsDNA-
driven dynamic translocation of STING and the innate immune response.
Proc. Natl. Acad. Sci. USA. Published online November 19, 2009. 10.1073/
pnas.0911267106.
Sasai, M., Shingai, M., Funami, K., Yoneyama, M., Fujita, T., Matsumoto, M.,
and Seya, T. (2006). NAK-associated protein 1 participates in both the TLR3
and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177,
8676–8683.
Satoh, S., Kato, H., Kumagai, Y., Yoneyama, M., Sato, S., Matsushita, K., Tsu-
jimura, T., Fujita, T., Akira, S., and Takeuchi, O. (2010). LGP2 is a positive regu-
lator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci.
USA 107, 1512–1517.
Schlee, M., Roth, A., Hornung, V., Hagmann, C.A., Wimmenauer, V., Barchet,
W., Coch, C., Janke, M., Mihailovic, A., Wardle, G., et al. (2009). Recognition of
50 triphosphate by RIG-I helicase requires short blunt double-stranded RNA as
contained in panhandle of negative-strand virus. Immunity 31, 25–34.
Schmidt, A., Schwerd, T., Hamm,W., Hellmuth, J.C., Cui, S., Wenzel, M., Hoff-
mann, F.S., Michallet, M.C., Besch, R., Hopfner, K.P., et al. (2009). 50-triphos-
phate RNA requires base-paired structures to activate antiviral signaling via
RIG-I. Proc. Natl. Acad. Sci. USA 106, 12067–12072.
Schmitz, F., Heit, A., Guggemoos, S., Krug, A., Mages, J., Schiemann, M.,
Adler, H., Drexler, I., Haas, T., Lang, R., and Wagner, H. (2007). Interferon-
regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production
in myeloid dendritic cells. Eur. J. Immunol. 37, 315–327.
Sepulveda, F.E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E.,
Lennon-Dumenil, A.M., Amigorena, S., Cabanie, L., and Manoury, B. (2009).
Critical role for asparagine endopeptidase in endocytic Toll-like receptor
signaling in dendritic cells. Immunity 31, 737–748.
Sheedy, F.J., Palsson-McDermott, E., Hennessy, E.J., Martin, C., O’Leary, J.,
Ruan, Q., Johnson, D.P., Chen, Y., andO’Neill, L.A. (2009). Negative regulation
of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the
microRNA miR-21. Nat. Immunol. 11, 141–147.
Stetson, D.B., and Medzhitov, R. (2006). Recognition of cytosolic DNA acti-
vates an IRF3-dependent innate immune response. Immunity 24, 93–103.
Stetson, D.B., Ko, J.S., Heidmann, T., and Medzhitov, R. (2008). Trex1
prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587–598.
Subramanian, S., Tus, K., Li, Q.Z., Wang, A., Tian, X.H., Zhou, J., Liang, C.,
Bartov, G., McDaniel, L.D., Zhou, X.J., et al. (2006). A Tlr7 translocation accel-erates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103,
9970–9975.
Sumpter, R., Jr., Loo, Y.M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon,
S.M., and Gale, M., Jr. (2005). Regulating intracellular antiviral defense and
permissiveness to hepatitis C virus RNA replication through a cellular RNA heli-
case, RIG-I. J. Virol. 79, 2689–2699.
Sun, W., Li, Y., Chen, L., Chen, H., You, F., Zhou, X., Zhou, Y., Zhai, Z., Chen,
D., and Jiang, Z. (2009). ERIS, an endoplasmic reticulum IFN stimulator, acti-
vates innate immune signaling through dimerization. Proc. Natl. Acad. Sci.
USA 106, 8653–8658.
Tabeta, K., Hoebe, K., Janssen, E.M., Du, X., Georgel, P., Crozat, K., Mudd, S.,
Mann, N., Sovath, S., Goode, J., et al. (2006). The Unc93b1 mutation 3d
disrupts exogenous antigen presentation and signaling via Toll-like receptors
3, 7 and 9. Nat. Immunol. 7, 156–164.
Taganov, K.D., Boldin, M.P., Chang, K.J., and Baltimore, D. (2006).
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted
to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA
103, 12481–12486.
Takahashi, K., Kawai, T., Kumar, H., Sato, S., Yonehara, S., and Akira, S.
(2006). Roles of caspase-8 and caspase-10 in innate immune responses to
double-stranded RNA. J. Immunol. 176, 4520–4524.
Takahasi, K., Yoneyama, M., Nishihori, T., Hirai, R., Kumeta, H., Narita, R.,
Gale, M., Jr., Inagaki, F., and Fujita, T. (2008). Nonself RNA-sensing mecha-
nism of RIG-I helicase and activation of antiviral immune responses. Mol.
Cell 29, 428–440.
Takahasi, K., Kumeta, H., Tsuduki, N., Narita, R., Shigemoto, T., Hirai, R.,
Yoneyama, M., Horiuchi, M., Ogura, K., Fujita, T., and Inagaki, F. (2009). Solu-
tion structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains:
identification of the RNA recognition loop in RIG-I-like receptors. J. Biol.
Chem. 284, 17465–17474.
Takaoka, A., Wang, Z., Choi, M.K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miya-
gishi, M., Kodama, T., Honda, K., et al. (2007). DAI (DLM-1/ZBP1) is a cytosolic
DNA sensor and an activator of innate immune response. Nature 448,
501–505.
Takeuchi, O., and Akira, S. (2009). Innate immunity to virus infection. Immunol.
Rev. 227, 75–86.
Tal, M.C., Sasai, M., Lee, H.K., Yordy, B., Shadel, G.S., and Iwasaki, A. (2009).
Absence of autophagy results in reactive oxygen species-dependent amplifi-
cation of RLR signaling. Proc. Natl. Acad. Sci. USA 106, 2770–2775.
Tenoever, B.R., Ng, S.L., Chua, M.A., McWhirter, S.M., Garcia-Sastre, A., and
Maniatis, T. (2007). Multiple functions of the IKK-related kinase IKKepsilon in
interferon-mediated antiviral immunity. Science 315, 1274–1278.
Tian, J., Avalos, A.M., Mao, S.Y., Chen, B., Senthil, K., Wu, H., Parroche, P.,
Drabic, S., Golenbock, D., Sirois, C., et al. (2007). Toll-like receptor 9-depen-
dent activation by DNA-containing immune complexes ismediated by HMGB1
and RAGE. Nat. Immunol. 8, 487–496.
Tseng, P.H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D.A., and Karin, M.
(2009). Different modes of ubiquitination of the adaptor TRAF3 selectively acti-
vate the expression of type I interferons and proinflammatory cytokines. Nat.
Immunol. 11, 70–75.
Uematsu, S., Fujimoto, K., Jang, M.H., Yang, B.G., Jung, Y.J., Nishiyama, M.,
Sato, S., Tsujimura, T., Yamamoto, M., Yokota, Y., et al. (2008). Regulation of
humoral and cellular gut immunity by lamina propria dendritic cells expressing
Toll-like receptor 5. Nat. Immunol. 9, 769–776.
Viglianti, G.A., Lau, C.M., Hanley, T.M., Miko, B.A., Shlomchik, M.J., and
Marshak-Rothstein, A. (2003). Activation of autoreactive B cells by CpG
dsDNA. Immunity 19, 837–847.
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S.,
Kelly, K.M., Reeves, W.H., Bauer, S., and Krieg, A.M. (2005). Immune stimula-
tion mediated by autoantigen binding sites within small nuclear RNAs involves
Toll-like receptors 7 and 8. J. Exp. Med. 202, 1575–1585.
Warger, T., Hilf, N., Rechtsteiner, G., Haselmayer, P., Carrick, D.M., Jonuleit,
H., von Landenberg, P., Rammensee, H.G., Nicchitta, C.V., Radsak, M.P.,Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc. 819
and Schild, H. (2006). Interaction of TLR2 and TLR4 ligandswith the N-terminal
domain of Gp96 amplifies innate and adaptive immune responses. J. Biol.
Chem. 281, 22545–22553.
Xia, Z.P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., and
Chen, Z.J. (2009). Direct activation of protein kinases by unanchored polyubi-
quitin chains. Nature 461, 114–119.
Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K.,
Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., et al. (2004). Regulation of
Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein
IkappaBzeta. Nature 430, 218–222.
Yamasaki, S., Ishikawa, E., Sakuma, M., Hara, H., Ogata, K., and Saito, T.
(2008). Mincle is an ITAM-coupled activating receptor that senses damaged
cells. Nat. Immunol. 9, 1179–1188.
Yamasaki, S., Matsumoto, M., Takeuchi, O., Matsuzawa, T., Ishikawa, E.,
Sakuma, M., Tateno, H., Uno, J., Hirabayashi, J., Mikami, Y., et al. (2009).
C-type lectin Mincle is an activating receptor for pathogenic fungus, Malasse-
zia. Proc. Natl. Acad. Sci. USA 106, 1897–1902.
Yanai, H., Ban, T., Wang, Z., Choi, M.K., Kawamura, T., Negishi, H., Nakasato,
M., Lu, Y., Hangai, S., Koshiba, R., et al. (2009). HMGB proteins function as820 Cell 140, 805–820, March 19, 2010 ª2010 Elsevier Inc.universal sentinels for nucleic-acid-mediated innate immune responses.
Nature 462, 99–103.
Yarovinsky, F., Zhang, D., Andersen, J.F., Bannenberg, G.L., Serhan, C.N.,
Hayden, M.S., Hieny, S., Sutterwala, F.S., Flavell, R.A., Ghosh, S., and Sher,
A. (2005). TLR11 activation of dendritic cells by a protozoan profilin-like
protein. Science 308, 1626–1629.
Yoneyama, M., and Fujita, T. (2008). Structural mechanism of RNA recognition
by the RIG-I-like receptors. Immunity 29, 178–181.
Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira,
K., Foy, E., Loo, Y.M., Gale, M., Jr., Akira, S., et al. (2005). Shared and unique
functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral
innate immunity. J. Immunol. 175, 2851–2858.
Zeng, W., Xu, M., Liu, S., Sun, L., and Chen, Z.J. (2009). Key role of Ubc5 and
lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 36, 315–325.
Zhong, B., Yang, Y., Li, S., Wang, Y.Y., Li, Y., Diao, F., Lei, C., He, X., Zhang, L.,
Tien, P., and Shu, H.B. (2008). The adaptor protein MITA links virus-sensing
receptors to IRF3 transcription factor activation. Immunity 29, 538–550.
